Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000934623 | SCV001080350 | likely benign | Glycogen storage disease, type II | 2023-09-15 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002409217 | SCV002720843 | likely benign | Cardiovascular phenotype | 2020-07-07 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Fulgent Genetics, |
RCV000934623 | SCV002804594 | likely benign | Glycogen storage disease, type II | 2022-04-03 | criteria provided, single submitter | clinical testing | |
Natera, |
RCV000934623 | SCV001453432 | uncertain significance | Glycogen storage disease, type II | 2020-03-10 | no assertion criteria provided | clinical testing |